Swiss pharmaceutical giant Novartis said Wednesday it would not hike drug prices in the United States this year, following a similar decision by rival Pfizer amid pressure from the White House. “We don’t plan to take any further price increases in the United States for 2018,” Novartis chief executive Vas Narasimhan told journalists on an […]